Dr. Philip M. Batista, MD

Dr. Batista practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.

Dr. Batista's NPI, 1811216419, was assigned on May 20, 2010. Dr. Batista graduated from University of Connecticut School of Medicine in 2010. Dr. Batista holds New Jersey license 25MA10361400.

Dr. Batista's primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.

Dr. Batista's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dr. Batista is also affiliated with Virtua Voorhees Hospital. The medical group on file is Cooper University Physicians. Dmand AI also links Dr. Batista to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Batista practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Batista's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Batista's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 1,073 Medicare services from Dr. Batista across 18 procedure codes in 2024, for 446 Medicare patients. Medicare paid $113,559 for them.

CMS counts 446 Medicare patients who saw Dr. Batista in 2024. The largest group is 65 to 74, with 185 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Batista's median patient age at 70, with 46% women.

In 2024, Dr. Batista wrote 251 Medicare Part D claims for 60 patients. 97% of them were for generic drugs. CMS names the drug for 213 of them, across 2 drugs with 11 or more claims each, at $2,466 in total drug cost. In 2023, CMS named 207 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Batista for performance year 2024, reported as part of a group. Dr. Batista accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Batista as offering telehealth. CMS counts 15 procedures of leg revascularization (restoring blood flow) by Dr. Batista, more than 72% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Batista, published from 2012 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Education, Medical, Graduate, Extracorporeal Membrane Oxygenation and Giant Cell Arteritis. Dr. Batista has published most often in J Vasc Surg Cases Innov Tech. Dr. Batista's most frequent co-authors are Joseph V. Lombardi, MD, Katherine McMackin, MD and Jeffrey P. Carpenter, MD.

CMS Open Payments shows 296 general payments to Dr. Batista from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Medtronic, Inc. paid the most, $10,417.

Dr. Batista graduated from University of Connecticut School of Medicine in 2010.